Displaying drugs 6301 - 6325 of 6759 in total
Taniraleucel
Investigational
Pacmilimab
Pacmilimab is under investigation in clinical trial NCT04596150 (Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer).
Investigational
Allogeneic cytomegalovirus-specific cytotoxic T lymphocytes
Investigational
Paeonia lactiflora root
Experimental
2-Naphthalenesulfonic acid
Experimental
Iopofosine I-124
Investigational
Vemircopan
Investigational
ICG-001
Investigational
nor-NOHA
N-Hydroxy-nor-L-arginine (nor-NOHA) is under investigation in clinical trial NCT02009527 (Arginase Inhibition in Ischemia-reperfusion Injury).
Investigational
Racemetyrosine
Racemetyrosine is under investigation in clinical trial NCT03512756 (A Randomized Phase 2/3 Multi-center Study of SM-88 in Patients With Metastatic Pancreatic Cancer).
Investigational
Dazucorilant
Investigational
TBAJ-876
Investigational
alpha-Keto-beta-methylvaleric acid
Experimental
Toyocamycin
4-Amino-5-cyano-7-(D-ribofuranosyl)-7H- pyrrolo(2,3-d)pyrimidine. Antibiotic antimetabolite isolated from Streptomyces toyocaensis cultures. It is an analog of adenosine, blocks RNA synthesis and ribosome function, and is used mainly as a tool in biochemistry.
Experimental
Zinc monoethylfumarate
Experimental
Posoleucel
Investigational
Revumenib
Investigational
Displaying drugs 6301 - 6325 of 6759 in total